期刊文献+

组织因子及组织因子通路抑制物在脓毒症中的研究进展 被引量:4

原文传递
导出
摘要 近年来对于全身炎症反应综合征(SIRS)以及多器官功能障碍综合征(MODS)发生机制的研究愈来愈受到人们的重视,而有关SIRS的研究多来自对脓毒症患者的观察或脓毒症模型的研究,其中凝血功能紊乱在脓毒症中的作用日益引起学者的关注。组织因子(TF)作为外源性凝血途径的启动因子在凝血与炎症反应之间起到了重要作用,成为当前二者关系研究的焦点所在。
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2008年第1期62-64,共3页 Chinese Critical Care Medicine
  • 相关文献

参考文献28

  • 1姚咏明,盛志勇,林洪远,柴家科.脓毒症定义及诊断的新认识[J].中国危重病急救医学,2004,16(6):321-324. 被引量:307
  • 2Gando S, Nanzaki S, Sasaki S, et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock[J]. Crit Care Med, 1998,26(12) :2005-2009
  • 3Levi M, de Jonge E, van der Poll T. New treatment strategies for dissemi nated intravascular coagulation based on current understanding of the pathohysiology [J]. Ann Med, 2004,36 (1) : 41- 49.
  • 4Strukova S. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis[J]. Front Biosci, 2006,11:59-80.
  • 5Levi M,van der Poll T,ten Cate H. Tissue factor in infection and severe inflammation[J]. Semin Thromb Hemost, 2006,32 (1) : 33-39.
  • 6Vervloet M G,Thijs L G,Hack C E. Derangements of coagulation and fibri nolysis in critically ill patients with sepsis and septic shock[J]. Semin Thromb Hemost,1998,24(1) :33-44.
  • 7Opal S M. Phylogenetic and functional relationships between coagulation and the innate immune response [J]. Crit Care Meal,2000,28(9 Suppl) :S77-80.
  • 8MeVey J H. Tissue factor pathway[J]. Baillieres Best Pract Res Clin Haematol, 1999,12(3) : 361-372.
  • 9Chu A J. Role of tissue factor in throm bosis : coagulation-inflammation-thrombosis circuit [J]. Front Biosci, 2006,11 : 256-271.
  • 10Chu A J. Tissue factor mediates inflammation [J]. Arch Biochem Biophys, 2005,440(2) :123-132.

二级参考文献112

  • 1Matthias R, Wolfram R. Role of coagulation protease cascades in sepsis[J]. Critical Care, 2003, 7:123
  • 2Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient[J]. J Crit Care, 2001,16(4): 167
  • 3Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation [J]. Crit Care Med, 2001,29(7):S90
  • 4Bajaj MS, Birktoft JJ, Steer SA, et al. Structure and biology of tissue factor pathway inhibitor [J]. Thromb Haemost,2001,86(4):959
  • 5Sandset PM. Tissue factor pathway inhibitor (TFPI)-an update[J]. Haemostasis, 1996,26: 154
  • 6Asakura H, Ontachi Y, Mizutani T, et al. Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases[J]. Blood Coagul Fibrinolysis, 2001,12(1): 1
  • 7Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis[J]. Crit Care Med, 2000,28(9):S9
  • 8Bajaj MS, Bajaj SP. Tissue factor pathway inhibitor: potential therapeutic applications[J]. Thromb Haemost, 1997,78 (1): 471
  • 9Pernerstorfer T, Hollenstein U, Hansen JB, et al. Lepirudin blunts endotoxin-induced coagulation activation[J]. Blood,2000,95 (5): 1729
  • 10Lupu C, Kruithof EK, Kakkar VV, et al. Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons[J]. Thromb Haemost, 1999,82(6): 1652

共引文献322

同被引文献52

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部